VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by wasagastaron Mar 03, 2017 2:36pm

88 Views

Post# 25928754

RE:Univ. of Chicago (Cardiology) supports it

bencro wrote: This technology cannot have better support than Univ. of Chicago (Cardiology) ...

University of Chicago says...

“I expect that an assessment of RV volume and function using the VMS™ will become part of the routine clinical ultrasound evaluation for patients at risk for PAH.

A simple way to detect and monitor PAH is gravely needed and this methodology will be extremely useful to quantify interventions (therapeutic and surgical) performed on the right ventricle,” stated Roberto M. Lang, MD, is an internationally renowned cardiologist and specialist in echocardiography and Past President of the American Society of Echocardiography.

Heart and Vascular Center - The University of Chicago Medicine

Nationally Recognized Heart and Vascular Care

The University of Chicago Medicine is a leader in innovative, comprehensive patient care. Our cardiac and vascular experts have pioneered treatments and continue to make advancements in patient care. We are one of the nation's most comprehensive programs using robotic surgery for cardiovascular operations and a nationally acclaimed program in bloodless cardiac surgery and cardiovascular imaging.